Hainan
605199.SSHainan Huluwa Pharmaceutical Group Co., Ltd. Price (605199.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
394,436,231
(1.4177)%Revenue and Profitability
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 487,353,546 | 655,005,486 | 983,772,603 | 1,305,918,058 | 1,161,705,769 | 1,353,793,179 | 1,515,046,453 | 1,905,182,163 |
| Net Income | 33,762,899 | 22,127,905 | 100,538,817 | 120,329,315 | 121,502,482 | 72,137,858 | 85,681,971 | 106,497,782 |
| FCF USD | 23,976,749 | -67,615,130 | -41,019,504 | 86,117,418 | -56,115,247 | -35,140,077 | -153,610,854 | -460,947,397 |
| OCF USD | 64,964,800 | 89,962,551 | 31,796,623 | 144,512,810 | 3,299,892 | 102,483,892 | 238,711,442 | 28,252,316 |
Financial Health - DEBT
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 3.15 | 0.30 | 0.14 | 0.43 | 0.06 | 2.11 | 6.57 |
| D/E | 1.77 | 0.42 | 0.24 | 0.24 | 0.31 | 0.54 | 0.67 | 1.04 |
| CA/CL | 0.73 | 0.92 | 1.44 | 1.37 | 1.76 | 1.37 | 1.18 | 1.33 |
| TA/TL | 1.32 | 1.77 | 2.24 | 2.45 | 2.52 | 2.12 | 1.78 | 1.61 |
| Total Debt | 228,318,749 | 146,308,261 | 142,098,176 | 152,623,074 | 283,019,727 | 499,212,203 | 683,982,174 | 1,160,115,002 |
Management Performance
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| ROIC | 9.25% | 3.73% | 12.99% | 15.38% | 9.99% | 6.08% | 4.80% | 4.74% |
| ROE | 26.24% | 6.30% | 16.63% | 18.69% | 13.26% | 7.77% | 8.45% | 9.51% |
| ROA | 0.00% | 2.74% | 9.21% | 11.07% | 7.99% | 3.95% | 3.67% | 3.68% |
| NM % | 6.93% | 3.38% | 10.22% | 9.21% | 10.46% | 5.33% | 5.66% | 5.59% |
| FCF / R% | 0.00% | -10.32% | -4.17% | 6.59% | -4.83% | -2.60% | -10.14% | -24.19% |
| FCF / NI% | 71.02% | -305.56% | -40.80% | 71.57% | -46.18% | -50.52% | -181.27% | -409.29% |
| Operating Margin (OM) | 0.00 | 0.05 | 0.05 | 0.06 | 0.16 | 0.14 | 0.18 | 0.19 |
Per Share
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| EPS | 0.08 | 0.13 | 0.31 | 0.30 | 0.30 | 0.18 | 0.21 | 0.27 |
| SPS | 1.22 | 3.85 | 3.03 | 3.26 | 2.90 | 3.38 | 3.79 | 4.83 |
| OCPS | 0.16 | 0.53 | 0.10 | 0.36 | 0.01 | 0.26 | 0.60 | 0.07 |
| FCPS | 0.06 | -0.40 | -0.13 | 0.22 | -0.14 | -0.09 | -0.38 | -1.17 |
| BVPS | 0.32 | 2.06 | 1.86 | 1.61 | 2.29 | 2.33 | 2.54 | 2.94 |
Per Share - CAGR
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.08 | 0.13 | 0.31 | 0.30 | 0.30 | 0.18 | 0.21 | 0.27 |
| CAGR-SPS | 1.22 | 3.85 | 3.03 | 3.26 | 2.90 | 3.38 | 3.79 | 4.83 |
| CAGR-OCPS | 0.16 | 0.53 | 0.10 | 0.36 | 0.01 | 0.26 | 0.60 | 0.07 |
| CAGR-FCPS | 0.06 | -0.40 | -0.13 | 0.22 | -0.14 | -0.09 | -0.38 | -1.17 |
| CAGR-BVPS | 0.32 | 2.06 | 1.86 | 1.61 | 2.29 | 2.33 | 2.54 | 2.94 |